C1ORF56: A Promising Drug Target and Biomarker (G54964)

Target Name: C1orf56

NCBI ID: G54964

C1orf56

C1ORF56: A Promising Drug Target and Biomarker

C1ORF56 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidney. It is a part of the C1ORF gene family, which has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most promising aspects of C1ORF56 is its potential as a drug target. C1ORF56 has been shown to play a role in a number of cellular processes that are important for the development and progression of these diseases, including the regulation of cell growth, the formation of blood vessels, and the immune response.

One of the ways that C1ORF56 is thought to work is by regulating the activity of a protein called TGF-beta. TGF-beta is aTransforming growth factor that plays a key role in the regulation of cell growth, cell differentiation, and the formation of tissues. C1ORF56 has been shown to interact with TGF-beta and to regulate its activity. This suggests that C1ORF56 may be a useful target for drugs that are designed to inhibit the activity of TGF-beta.

Another potential mechanism by which C1ORF56 may be a drug target is its role in the regulation of the immune response. C1ORF56 has been shown to play a role in the development of antibodies, which are proteins that are produced by the immune system in response to the presence of foreign substances in the body. C1ORF56 has been shown to regulate the production and activity of antibodies, which suggests that it may be a useful target for drugs that are designed to inhibit the immune response.

In addition to its potential as a drug target, C1ORF56 also has a number of potential applications as a biomarker. For example, C1ORF56 has been shown to be expressed in a number of different tissues and has been used as a biomarker for a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that C1ORF56 may be a useful biomarker for these diseases and could be used in the development of new diagnostic tests and therapies.

Overall, C1ORF56 is a protein that has a number of potential applications as a drug target and biomarker. Its interaction with TGF-beta and its role in the regulation of cell growth, the formation of blood vessels, and the immune response make it a promising target for drugs that are designed to inhibit these processes. As more research is done on C1ORF56, it is likely to become a valuable tool for the treatment of a wide range of diseases.

Protein Name: Chromosome 1 Open Reading Frame 56

Functions: Involved in control of cellular proliferation. Onconcogenic modifier contributing to the tumor suppressor function of DNMT3B

The "C1orf56 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C1orf56 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets